Empleo de sacubitrilo-valsartán, rurosemida y levosimendán en un paciente pluripatológico con insuficiencia cardíaca descompensada

Javier Béjar-Valera; Pilar Egea-Serrano

doi:10.32818/reccmi.a5s1a6

Use of sacubitril-valsartan, furosemide and levosimendan in a multi-pathological patient with decompensated heart failure

Authors

Javier Béjar-Valera Servicio de Medicina Interna, Hospital General Universitario Rafael Méndez, Lorca (Murcia), Spain
Pilar Egea-Serrano Servicio de Cardiología, Hospital General Universitario Rafael Méndez, Lorca (Murcia), Spain

DOI:

https://doi.org/10.32818/reccmi.a5s1a6

Keywords:

heart failure diastolic, atrial fibrillation, multimorbidity.

Abstract

A 69-year old male hypertensive, dyslipidaemic, ex-smoker and former drinker, permanent atrial fibrillation and chronic ischemic heart disease. He goes to the Emergency Department due to minimal effort dyspnea and is arrhythmic and with pulmonary bibasal crackles. In hospitalization, implantation of implantable automatic defibrillator is performed due to streaks of non-sustained ventricular tachycardia. Sacubitril-valsartan is started, which is suspended due to new decompensation of heart failure. At this time, it is scheduled every two weeks in the day hospital for administration of intravenous levosimendan and furosemide, and thus, sacubitril-valsartan can be reintroduced at progressive doses.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal. 2016 Jul; 37(27): 2129-2200. doi: https://doi.org/10.1093/eurheartj/ehw128.

Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. European Heart Journal. 2016 Oct; 37(28): 2893-2962. doi: https://doi.org/10.1093/eurheartj/ehw210.

Downloads

PDF (Español (España))

Published

2020-03-31

How to Cite

Béjar-Valera J, Egea-Serrano P. Use of sacubitril-valsartan, furosemide and levosimendan in a multi-pathological patient with decompensated heart failure. Rev Esp Casos Clin Med Intern [Internet]. 2020 Mar. 31 [cited 2024 Dec. 22];5:15-6. Available from: https://www.reccmi.com/RECCMI/article/view/510

Download Citation

Issue

Vol. 5 (2020): Suplemento. Paciente pluripatológico y edad avanzada

Section

CLINICAL CASES

License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Permite compartir, copiar y redistribuir el material en cualquier medio o formato, bajo los siguientes términos:

Reconocimiento: debe otorgar el crédito correspondiente, proporcionar un enlace a la licencia e indicar si se realizaron cambios. Puede hacerlo de cualquier manera razonable, pero no de ninguna manera que sugiera que el licenciante lo respalda a usted o su uso.

No comercial: no puede utilizar el material con fines comerciales.

No Derivados: si remezcla, transforma o construye sobre el material, no puede distribuir el material modificado.

Sin restricciones adicionales: no puede aplicar términos legales o medidas tecnológicas que restrinjan legalmente a otros de hacer cualquier cosa que permita la licencia.